FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 39 filers reported holding FUSION PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $29,658,000 | -24.6% | 3,670,516 | 0.0% | 3.03% | -40.5% |
Q1 2021 | $39,348,000 | -8.8% | 3,670,516 | 0.0% | 5.10% | -8.4% |
Q4 2020 | $43,129,000 | -2.2% | 3,670,516 | 0.0% | 5.56% | -37.4% |
Q3 2020 | $44,120,000 | -31.2% | 3,670,516 | 0.0% | 8.88% | -29.5% |
Q2 2020 | $64,124,000 | – | 3,670,516 | – | 12.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,670,516 | $11,562 | 3.36% |
ADAMS STREET PARTNERS LLC | 2,947,809 | $9,285,598 | 3.10% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,560,984 | $4,917,100 | 2.14% |
Sio Capital Management, LLC | 260,448 | $820,411 | 0.30% |
BRAIDWELL LP | 2,000,000 | $6,300,000 | 0.21% |
Orbimed Advisors | 3,224,770 | $10,158,026 | 0.19% |
TPG GP A, LLC | 2,551,794 | $8,038,151 | 0.16% |
Artal Group S.A. | 750,000 | $2,363 | 0.13% |
RA Capital Management | 659,992 | $2,078,975 | 0.04% |
SECTORAL ASSET MANAGEMENT INC | 57,297 | $180,486 | 0.04% |